EUVIMEDEUVIMED entdecken
Crossref

Research Progress on Traditional Chinese Medicine Treatment of Viral Myocarditis

MEDS Chinese Medicine · 2026 · 8 (1)

DOI: 10.23977/medcm.2026.080109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MEDS Chinese Medicine, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral Myocarditis (VMC) is an inflammatory condition of the myocardium caused by infections such as Coxsackie B viruses. Traditional Chinese Medicine classifies it under categories such as "palpitations" and "heart-related disorders," with "deficiency, toxin, and stasis" as the core pathogenesis. This paper systematically reviews the research progress on the treatment of VMC with traditional Chinese medicine: active components of Chinese herbal medicines, such as puerarin, astragaloside I, total saponins of Panax notoginseng, and berberine, can protect the myocardium through antiviral, antioxidant, and anti-inflammatory mechanisms; Compound formulas such as Shengmai San and Yiqu Jiedu Tang, as well as proprietary Chinese medicines like Shenmai Injection and Xiaochaihu Granules, have demonstrated definite efficacy in improving clinical symptoms and regulating immune function; external therapies such as acupuncture and acupoint plaster application have also shown unique advantages, providing important references for the comprehensive prevention and treatment of VMC.

Zitieren

APA

(2026). Research Progress on Traditional Chinese Medicine Treatment of Viral Myocarditis. MEDS Chinese Medicine, 8(1). https://doi.org/10.23977/medcm.2026.080109

Vancouver

Research Progress on Traditional Chinese Medicine Treatment of Viral Myocarditis. MEDS Chinese Medicine. 2026;8(1). doi:10.23977/medcm.2026.080109

BibTeX
@article{euvimed2026,
  title = {Research Progress on Traditional Chinese Medicine Treatment of Viral Myocarditis},
  journal = {MEDS Chinese Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.23977/medcm.2026.080109}
}
Kostenlos starten →